Heritability of Alzheimer-related plasma biomarkers in the Amish population
Abstract
INTRODUCTION
Plasma biomarkers for Alzheimer disease (AD) hold promise for disease diagnosis and prediction, yet their genetic underpinnings remain underexplored.
METHODS
We measured plasma amyloid beta 40 (Aβ40), Aβ42, Aβ42/Aβ40, total tau (t-tau), phosphorylated tau 181 (p-tau181), Aβ42/t-tau, Aβ42/p-tau181, neurofilament light chain, and glial fibrillary acidic protein in the Midwestern Amish. Pedigree-based heritability<inline-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="25327557v2_inline1.gif"/></inline-formula>was estimated from multigenerational pedigrees, and SNP-based heritability<inline-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="25327557v2_inline2.gif"/></inline-formula>was derived from single nucleotide polymorphisms (SNPs).
RESULTS
Among all Amish individuals, additive genetic effects<inline-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="25327557v2_inline3.gif"/></inline-formula>explained 11.1% to 36.6% of biomarker variances.<inline-formula><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="25327557v2_inline4.gif"/></inline-formula>estimates were consistently lower, ranging from 6.7% to 28.7%. The heritability of these biomarkers in subgroups of cognitively normal individuals andAPOEε4 non-carriers yielded similar results.
DISCUSSION
Plasma biomarkers such as amyloid β, t-tau, and p-tau181 are moderately heritable in the Amish, underscoring the impact of genetic determinants of plasma biomarkers associated with AD.
Related articles
Related articles are currently not available for this article.